NCIA’s Hemp Committee Lobbies Congress in D.C. - James Granger and Chris Hope
Play • 30 min

Live from DC, Lobbying for the cannabis industry, most were talking to Congressional offices about SAFE Banking, 280E, and comprehensive reform like the CAOA. We discuss what was the focus of the hemp team during their meetings with members of Congress. As wellas, what was the guest's overall strategy? 

James Granger has built an extensive career focused on the blooming medical and recreational cannabis industry and holds a deep knowledge of cannabinoid effects, extraction, and processing, cannabis chemistry, regulation, management, consulting, politics, operations, product development, and more. In 2018, James joined The Clear (Now Clear Colorado Group) team to re-build and streamline operations, Now, as Chief Political Officer of Clientele Capital, a Denver-based venture capital firm that provides funding and strategic consulting to growth-oriented companies in emerging markets, James spearhead’s the company’s goals of staying ahead of extensive regulatory changes, challenges and nuances the company may face in the new developing cannabis industry.

Chris Hope has 20 years of experience in the cannabis industry. He founded, Sequoia Wellness (SW), a retail cannabis delivery service in 2013, serving the Los Angeles area. In 2016, he founded Sequoia Management Group (SMG), as a cannabis & hemp business development and consulting company. Today, SMG is focusing on the burgeoning industrial hemp industry with a focus on fiber, food, grain, seed, and building materials. Chris was, a founding member and Director of Member & Sponsor Relations for Angeles Emeralds (AE), a cannabis advocacy and lobbying group for Los Angeles County. As a member of the National Cannabis Industry Association (NCIA) since 2015, and In 2020, Chris became the Committee Organizer for the Hemp Committee (HC) with NCIA for the 2020/21 term. He now serves as the Chair for the HC, as well as contributing to both the NCIA Sustainability Collaboration/Council and the Novel, Synthetic, and Minor Cannabinoid Collaboration. 

Advertising Inquiries:

Privacy & Opt-Out:
More episodes
Clear search
Close search
Google apps
Main menu